The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)
ACTIVE_NOT_RECRUITING
Status
Conditions
Interventions
- DRUG: Sulindac 400 MG
- OTHER: Placebo
Sponsor
Duke University
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]